MP41-12 AVELUMAB FIRST-LINE MAINTENANCE PLUS BEST SUPPORTIVE CARE VS BEST SUPPORTIVE CARE ALONE FOR ADVANCED UROTHELIAL CARCINOMA: ANALYSIS OF TIME TO END OF NEXT-LINE THERAPY IN JAVELIN BLADDER 100

Petros Grivas,Se Hoon Park,Eric Voog,Evgeny Kopyltsov,Howard Gurney,David Queiroz Borges Muniz,Frédéric Rolland,Anne Birgitte Als,Begoña P Valderrama,Jing Wang,Nuno Costa,Robert J Laliberte,Alessandra di Pietro,Thomas Powles,Joaquim Bellmunt

The Journal of urology/The journal of urology（2021）

引用 0|浏览8

暂无评分

摘要

INTRODUCTION AND OBJECTIVE:Avelumab first-line (1L) maintenance is approved in various countries for patients (pts) with advanced urothelial carcinoma (UC) that has not progressed with 1L platinum-...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要